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Heme Induces the Expression of Adhesion 
Molecules ICAM-1, VCAM-1, and E Selectin 
in Vascular Endothelial Cells (44197)
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Abstract Heme is an important immunostimulating agent and oxidative factor con­
tributing to endothelial cell activation. To investigate the mechanism of heme-induced 
endothelial cel! activation, we analyzed the effect of heme and the inflammatory cy­
tokine, tumor necrosis factor-a (TNF-<x), on the expression of the heme-degrading 
stress protein, heme oxygenase (HO), and adhesion molecules in human umbilical 
vein endothelial cells (HUVEC). Indirect immunofluorescence double labeling studies 
demonstrated a simultaneous increase of ICAM-1 and HO-1 after exposure of cells to 
heme for 24 hr. Co-expression of HO-1 and ICAM-1 was also demonstrated in TNF-a- 
exposed cells. Dot blot immunoassay and quantitative analysis by ELISA demon­
strated that heme treatment for 24 hr caused a 2-fold increase in ICAM-1 expression (P
< 0.002) compared with quiescent cells, while in cells stimulated by TNF-a for 24 hr 
ICAM-1 gene expression increased by 5~fold. Moreover, heme exposure also resulted 
in a marked increase in VCAM-1 and E selectin expression (three and four times over 
control levels, respectively). On the other hand, TNF-a treatment showed similar ex­
pression levels for VCAM-1 and E selectin, compared with stimulation by heme (100 
\iAQ. The level of HO activity in endothelial cells exposed to heme or TNF-a was 
increased from 24.7 ± 5.7 pmol bilirubin/mg protein/min in control to 70.0 ± 9.5 and 
36.7 ±3.1 pmol biiirubin/mg protein/min in heme- and TNF-ce-stimulated cells, respec­
tively. These results suggest that upregulation of ICAM-1, VCAM-1, and E selectin 
expression is associated with oxidative stress induced by hemoglobin/heme and that 
HO-1 may play a modulating role via its ability to degrade heme to a substance with
antioxidant properties. [P.S.E.B.M. 1997, Vol 216]
Heme proteins play a vital role in diverse biological processes including cell respiration, energy genera­tion, oxidative biotransformation, and growth/ 
differentiation (1-3). The ubiquitous heme molecule has 
multiple immunoregulatory effects, which include the in­
duction of cytokine production, such as tumor necrosis fac­
tor-a (TNF-a), interleukin-1 (IL-1), and IL-8 in mono­
nuclear cells (4-7). However, heme also constitutes a major
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danger to vascular integrity by making the endothelium hy­
persensitive to oxidative damage (8-10). Oxidative damage 
includes lipid peroxidation resulting in loss of membrane 
integrity (11, 12) and structural alterations to DNA (13, 14). 
Free heme, which is highly hydrophobic, accumulates in the 
membranes of endothelial cells and acts in synergy with 
oxygen radicals to exacerbate oxidative damage (8). Iron 
released from the heme molecule is critical to this oxidative 
sensitization since ferritin synthesis is essential for protec­
tion against the cytotoxic effect of heme (15). Oxidative 
injury of the endothelium, due to a gross imbalance between 
the generation of reactive oxygen species (ROS) and the 
antioxidant defenses of the cell, has been implicated in the 
pathogenesis of a number of pathological conditions, in­
cluding hemorrhagic injury, ischemia/reperfusion injury, 
adult respiratory distress syndrome, and atherosclerosis (11,
16-19).
Heme oxygenase (HO) is the rate-limiting enzyme in 
heme degradation. Among the two isoforms of HO, HO-1 is
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highly responsive to stress and is induced by a variety of 
agents, such as H20 2, heavy metals, endotoxin, and heme, 
in several cell types, including endothelial cells (20, 21). 
Upregulation of HO-1 gene expression results in increase of 
the degradation of heme to equimolar amounts of carbon 
monoxide, iron, and the antioxidant biliverdin (22). Iron by 
itself is a potent oxidative stress agent, whereas the iron 
released by HO-1 activity further enhances ferritin synthesis 
and thereby its sequestering (23). In this regard, overexpres­
sion of HO-1 in endothelial cells has been shown to protect 
from heme- and hemoglobin-mediated toxicity (19), and is 
associated with increased tolerance of the cell to ischemia 
and trauma in a variety of tissues (24, 25).
During the inflammatory response, the endothelium 
plays a critical role in the communication between the un­
derlying site of inflammation and circulating leukocytes. 
Cytokines released from the inflamed tissue induce endo­
thelial cells to express adhesion molecules on their cell sur­
face, including intercellular adhesion molecule-1 (ICAM- 
1), vascular adhesion molecule-1 (VCAM-1), and endothe­
lial leukocyte adhesion molecule (E-selectin) (26, 27), 
ICAM-1, VCAM-1, and E selectin on endothelial cells are 
able to interact specifically with ligands of passing leuko­
cytes, promoting the recruitment, adherence, and extrava­
sation of hematopoietic cells (28), which is thought to con­
tribute to the pathogenesis of neurodegenerative diseases 
(29), sickle cell crisis (30), and vascular diseases like ath­
erosclerosis (31). This is illustrated by the fact that sickle­
cell reticulocytes express glycoprotein IV (GP-IV) and 
VLA-4, which may mediate binding to activated endothelial 
cells and initiate vascular occlusion in sickle-cell anemia
(32). Cytokine-induced adhesion molecule expression and 
monocyte sequestration is also an important event in ath- 
erogenesis (33). In addition, activated neutrophils interact­
ing with the activated microvascular endothelium, readily 
release ROS, which can contribute to free radical-mediated 
reperfusion injury, leading to endothelial cell injury (34, 
35).
The mechanism by which heme and other factors in­
duce HO-1 involves the activation of various promoter sites, 
including nuclear factor kB (NF-kB) and activator protein 2 
(AP-2) responsive elements (1). NF-kB is involved in 
growth control and the rapid induction of various genes 
encoding defense and stress proteins (36). Cytokines, such 
as TNF-a and IL-1, activate NF-kB and modulate adhesion 
molecule expression on a variety of cells (36). ICAM -1, 
VCAM-1, and E selectin possess the regulatory sequences 
for the binding of NF-kB, and AP-2, and/or AP-1 in their 
promoter region (36-39). Since TNF-a and heme are major 
immunomodulators that share common features with re­
spect to NF-kB activation, we considered that heme may 
have direct modulatory effects on adhesion molecules. In 
the present report, we examined the effects of heme and 
TNF-a on the coordinate expression of HO-1 and adhesion 
molecules ICAM-1, VCAM-1, and E selectin in human um­
bilical vein endothelial cells (HUVEC). Our results indicate
that heme, in addition to its ability to induce HO-1 expres­
sion, is a potent inducer of ICAM-1, VC AM-1, and E se­
lectin expression in endothelial cells, which may emphasize 
its importance in biological processes.
Materials and Methods
Reagents. Hemin (Sigma Chemical Co., St. Louis, 
MO) solution was prepared as previously described (3). 
Human recombinant TNF-a was obtained from Endogen 
(Cambridge, MA).
Antibodies. The following antibodies were used: a 
rabbit polyclonal HO-1 antibody directed against human 
HO-1 (Affinity Bioreagents, Golden, CO), a monoclonal 
mouse CD62E antibody against human E selectin (Pharm- 
ingen, San Diego, CA), a REK-1 monoclonal mouse anti­
body against human ICAM-1, a kind gift from Yvette van 
Kooyk (Academic University Hospital, Nijmegen, The 
Netherlands), and a mouse monoclonal 4B9 antibody 
against human VCAM-1, which was generously provided 
by Roy Lobb (Biogen Inc., Cambridge, MA). Horseradish 
peroxidase-conjugated sheep anti-mouse IgG (Boehringer 
Mannheim, Germany) was used as secondary antibody for 
the chemiluminscence studies. For fluorescence studies, we 
used as secondary antibodies goat anti-rabbit IgG coupled to 
the fluorochrome rhodamine (Pierce, Rockford, IL), and 
Cy-2 fiuorochrome-conjugated to goat anti mouse IgG 
(Amersham/Life Sciences, Arlington Heights, IL). For en­
zyme-linked immunosorbent assay (ELISA), alkaline phos­
phatase (AM)-conjugated goat anti-mouse-IgG (H+L) 
(Gibco BRL, Grand Island, NY) was used as secondary 
antibody.
Cell Culture and Incubations. HUVEC (second
passage), kindly provided by Eric Jaffe (New York Hospi­
tal, New York, NY), were passaged two to four times and 
used in the experiments described below. Cells were cul­
tured in 199 medium containing 16% fetal calf serum, 4% 
human serum, 25 mM  HEPES, antibiotics-antimycotics and 
endothelial cell growth factor, at 37°C, at 5% C02.
Indirect Immunofluorescence Detection of 
ICAM-1 and HO-1 Expression. HUVEC were grown
on fibronectin-coated cover glasses to 70% confluency, and 
subsequently treated with heme (100 jjlM), TNF-a (20 ng/ 
ml), or a combination of both, for 24 lor. The cells were 
carefully washed with phosphate-buffered saline (PBS)(0.1 
g/1 CaCl2/MgCl2), and fixed with 80% acetone for 5 min at 
room temperature. After being washed twice with PBS/ 
0.05% Tween 20 (PBST), the cells were incubated with 5% 
bovine serum albumin (BSA) in PBST for 1 hr at room 
temperature. Protein expression was evaluated by indirect 
fluorescence using primary antibodies against ICAM-1 and/ 
or HO-1. After incubation for 1 hr at room temperature, the 
cells were washed three times with PBST, followed by in­
cubation for 1 hr with fluorescent-labeled secondary anti­
bodies and washing for three times with PBST. The cover 
glasses were mounted with one drop of aqua polymount
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(Poly sciences, Warrington, PA), and analyzed using fluo­
rescence microscopy.
Chemiluminescent Detection of Cellular Adhe­
sion Molecule Expression. Control and treated 
HUVEC were washed twice using cold PBS (0.1 g/1 CaCl2/ 
MgCl2), incubated with ice-cold Giordano buffer (50 mM
Tris/HCl [pH = 7.4], 0.25 M  NaCl, 0.1 % Triton X-100, 5 
mMl EDTA, 50 mM  NaF, 0.1 mM Na Orthovanadate, 0.5 
mM phenyl-methylsulfonyl fluoride), and gently scraped. 
The cell preparation was incubated for 30 min on ice, and 
vortexed. After centrifugation, the protein content of the 
supernatant was determined by the method of Lowry (40). 
One hundred micrograms of total protein was then trans­
ferred to nitrocellulose membranes using the minifold II 
slotblotter (Schleicher & Schuell, Keene, NH), crosslinked 
by UV light, and incubated for 1 hr with 1 % blocking buffer 
at room temperature. Membranes were then incubated with 
appropriate dilutions of the primary antibodies against 
ICAM-1, VCAM-1, and E selectin in 0.5% blocking buffer 
for 1 hr at room temperature, washed twice with Tris- 
buffered saline containing 0.05% Tween 20 (pH = 
8.0)(TBST), and incubated with horseradish peroxidase- 
conjugated secondary antibodies for 1 hr at room tempera­
ture. After membranes were washed with TBST, proteins 
were detected by chemiluminescence and the bands repre­
senting the expressed adhesion molecules were quantified 
by scanning densitometry. The results are presented as ar­
bitrary units of absorbance at 560 nm (AU) (Beckman spec­
trophotometer DU 7400).
Endothelial Cell ELISA for Surface Expression 
of ICAM-1, VCAM-1, and E Selectin. Aliquots of
HUVEC were grown in 24-well plates to near confluence 
(95%), followed by exposure to heme, TNF-a, or a combi­
nation thereof for 24 hr. The cells were washed with PBS 
(0.1 g/1 CaCl2/MgCl2) and fixated with 500 jxl/well 2*5% 
paraformaldehyde for 10 min at room temperature. Cells 
were washed with PBS and incubated for 2 hr with anti­
bodies against ICAM-1, VCAM-1, and E selection (1:1000 
dilution in PBS) at room temperature. Cells were washed 
three times and incubated for another hour with AP- 
conjugated goat anti-mouse IgG (H+L)(1:000 dilution in 
PBS) at room temperature and washed three times with 
PBS. Binding of the secondary antibody was determined by 
the addition of 350 |jl1 of p-nitrophenyl phosphate substrate 
(Sigma) (1 mg/ml in 0.2 M  Tris [pH 9.8], containing 5 mM  
MgCl2). The 24-well plate was incubated in the dark for 30 
min, and the reaction was terminated by the addition of 150 
/xl of 3 M  NaOH. The solution was transferred into 96-well 
plates and absorbance was read at 405 nm by an ELISA 
microplate reader. The surface expression of ICAM-1, 
VCAM-1, and E selectin is shown as mean ± SD of the 
optical density (OD) at 405 nm. OD in the absence of pri­
mary antibody serves as the blank value. The values are the 
mean of four experiments using triplicate wells.
Measurement of HO Activity. HO activity was as­
sayed by preparing microsomes from HUVEC treated with
heme, TNF-a, or a combination of both. Microsomes were 
incubated with 50 jj\M  heme, 2 mg/ml rat liver cytosol 
(source of biliverdin reductase), 1 mM  MgCl2, 3 units glu- 
cose-6-phosphate dehydrogenase, 1 mM  glucose-6- 
phosphate, and 2 mM  NADP+ in 0.5 ml 0.1 M  potassium 
phosphate buffer [pH = 7.4] for 30 min at 37°C. The re­
action was stopped by placing the tubes on dry ice, and 
bilirubin was extracted with chloroform as previously de­
scribed (41). The amount of bilirubin generated was deter­
mined by using a scanning spectrophotometer (Lambda 17 
UV/VIS; Perkin-Elmer, Norwalk, CT) and defined as the 
difference between 464 and 530 nm (41). Results are ex­
pressed as picomoles of bilirubin per milligram of protein 
per minute.
Results
Visualization of HO-1 and ICAM-1 Proteins Us­
ing Indirect Immunofluorescence. We employed in­
direct immunofluorescence double labeling to simulta­
neously visualize the expression of ICAM-1 and HO-1 after 
exposure of the cells to heme, and/or TNF-a. We observed 
that 24-hr incubation of HUVEC with 100 U/ml TNF-a 
resulted in the simultaneous expression of HO-1 and 
ICAM-1 (Fig. 1A). TNFa-treated cells showed a distinctive 
expression pattern of ICAM-1 on the cell surface, while 
HO-1 seemed to be widely expressed within the cell. Fur­
thermore, TNF-a caused an apparent morphological change 
of the HUVEC from a spherical appearance to a more elon­
gated shape.
Incubation of HUVEC for 24 hr with 100 \xM heme 
resulted in an enhanced co-expression of HO-1 and of 
ICAM-1 (Fig. IB). The cell surface expression pattern of 
ICAM-1 differs from the cells incubated with TNF-a in its 
dispersed distribution of ICAM-1 over the cell membrane, 
and the higher level of HO-1 expression. No significant 
morphology changes were apparent after treatment with 
heme.
Indirect immunofluorescence single labeling showed 
that HO-1 was also highly induced when HUVEC were 
incubated with 100 \lM  heme and 100 U/ml TNF-a for 24 
hr (Fig. 1C).
The Effect of Heme and TNF-a on Adhesion 
Molecule Expression in Endothelial Cells as Mea­
sured by Chemiluminescent Dot Blot Immunoas­
say. To confirm the immunofluorescence results, we fur­
ther determined the effect of heme and TNF-a on the cel­
lular adhesion molecule content by dot blot immunoassay 
techniques. HUVEC were incubated with heme (50 jsM) or 
TNF-a (20 ng/ml) for 24 hr, and cell lysates were then 
analyzed for the expression of ICAM-1, VCAM-1, and E 
selectin. Densitometry analysis performed after chemilumi­
nescence, showed that untreated HUVEC expressed 
ICAM-1 (Fig. 2) and VCAM-1 (data not shown) constitu- 
tively, while E selectin (data not shown) could not be de­
tected. After treatment for 24 hr with a single dose of heme 
(50 (ulM) or TNF-a (20 ng/ml), the expression level of the
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Figure 1, ICAM-1 and HO-1 expression of HUVEC, visual­
ized by indirect immunofluorescence. The expression of 
HO-1 is represented by the red appearance of rhodamine. 
The expression of ICAK/M is represented by the green fluo- 
rochrome Cy-2. The yellow appearance represents a com­
bination of both green and red fluorescent labels. (Magnifi­
cation: x100,) (A) ICAM-1 and HO-1 expression of HUVEC 
treated with 100 U/ml TNF-a for 24 hr, visualized by indirect 
immunofluorescence double labeling. (B) ICAM-1 and HO-1 
expression of HUVEC treated with 100 \iMheme for 24 hr, 
visualized by indirect immunofluorescence double labeling. 
(C) HO-1 expression of HUVEC treated with 100 \xM heme 
and 100 U/ml TNF-a for 24 hr, visualized by indirect immu­
nofluorescence sjngle labeling.
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adhesion molecules were analyzed. ICAM-1 expression af- Endothelial Cell ELISA for Surface Expression
ter heme stimulation was 4.4-fold over the control values (P  of ICAIVM, VCAM-13 and E Selectin. To quantify fur-
< 0.03), while in TNF-a-treated cells ICAM-1 expression ther the inductive effect of heme on the expression of ad- 
was 6-fold higher (P = 0.051) (Fig. 2). Similarly, VCAM-1 hesion molecules, we employed ELISA for the cell surface
expression of ICAM-1, VCAM-1, and E selectin in 
HUVEC. Treatment of HUVEC with different concentra-
and E selectin expression showed to be increased after ex­
posure to heme or TNF-a, as compared to untreated cells 
(data not shown). tions of heme for 24 hi* resulted in a significant concentra-
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sion of ICAM-1 of about 5-fold compared with nontreated 
cells (Fig. 3B). VCAM-1 surface expression in HUVEC 
was markedly increased by 3-fold compared with control 
levels after exposure to heme (100 jjlM) for 24 hr (P < 0.02) 
(Fig. 3C) TNF-a showed a 2.5-fold increase in VCAM-1 
expression (Fig. 3D). In addition, heme (100 jjlM )  increased 
the expression of E selectin by 4-fold in comparison with 
untreated cells (Fig. 3E). TNF-a mediated ICAM-1 expres­
sion was about 2.5-fold higher compared with cells exposed 
to heme (100 \xM) for 24 hr, but TNF-a~stimulated 
VCAM-1 and E selectin expression was similar to that 
stimulated by heme (100 jjiM )  (Figs. 3, D and F), Although 
the addition of heme tended to increase TNF-a-mediated 
ICAM-1 and E selectin expression, this was not significant 
(P > 0.05) (Figs. 3, B and F). However, TNF-a-mediated 
VCAM-1 expression was significantly enhanced, when 
HUVEC were co-exposed to heme (100 jj\M)(P < 0.03)(Fig. 
3D).
The Effect of Heme and TNF-a on HO Activity.
In parallel experiments, we examined the effects of heme 
and TNF-a on HO activity (Fig, 4). This was of particular 
tion-related increase in the surface expression of ICAM-1 interest since heme and TNF-a were found to be significant 
(Fig. 3A). Heme at 100 \xM caused a 2-fold increase in inducers of adhesion molecules in HUVEC (Figs. 1-3), as 
ICAM-1 expression compared to control values (P < 0.002). well as HO-1 expression (Fig, 1). As seen in Figure 4, heme 
TNF-a (20 ng/ml) caused an increase in cell surface expres- (50 \xM) was a powerful inducer of HO activity in HUVEC,
Figure 2. The expression of ICAM-1 was examined by immunoche- 
miluminescent dot blot assay of isolated total proteins after exposure 
of HUVEC monolayers to heme (50 p/l^, or TNF-a (20 ng/ml) for 24 
hr. The expression was quantitated by densitometry and represented 
as arbitrary units of absorbance at 560 nm (AU). Results show the 
mean ± SD of three separate experiments. Significance was defined 
by Student’s /tests, /^values exceeding 0.05 were considered not to 
be significant, (^Significantly different from control value; P< 0.03.)
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Figure 3. The effect of heme on endothelial surface expression of ICAM-1, VCAM-1, and E selectin in cultured endothelial cells was analyzed 
using ELISA. HUVEC subconfluent monolayers in 24-well plates were exposed for 24 hr to heme (50 \\M; 100 \\M), TNF-a (20 ng/ml), or 
combinations thereof. ICAM-1, VCAM-1, and E selectin expression was assayed by ELISA by measuring absorbance at 405 nm. Results show 
the mean ± SD of four separate experiments (triplicate). The data are presented as arbitrary units of absorbance at 405 nm (AU), (A) 
Expression of ICAM-1 after stimulation with heme (50 \\M; 100 \xM) for 24 hr. (B) Expression of ICAM-1 after exposure to TNF-a (20 ng/ml), 
with or without heme (50 \\M; 100 \\M) for 24 hr. (C) Expression of VCAM-1 after stimulation with heme (50 \\M; 100 \\M) for 24 hr. (D) 
Expression of VCAM-1 after exposure to TIMF-a (20 ng/ml), with or without heme (50 \\M; 100 \iM) for 24 hr. (E) Expression of E selectin after 
stimulation with heme (50 \sM; 100 \\M) for 24 hr. (F) Expression of E selectin after exposure to TNF-a (20 ng/ml), with or without heme (50 
yM; 100 \\M) for 24 hr. Significance was defined by Student’s /  tests, lva lues exceeding 0.05 were considered not to be significant. 
Significantly different from control: *P< 0.01; **P< 0,03. Significantly different from TNF-a: +P< 0.03
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Figure 4. HO activity of HUVEC treated with combinations of heme 
(50 \)A4) and TNF-a (20 ng/ml) for 24 hr. Activity is expressed as 
picomoles of bilirubin per milligram protein per minute. Significance 
was defined by Student’s / tests. P values exceeding 0,05 were 
considered not to be significant. Significantly different from control: 
*P< 0.003; **P< 0.035.
increasing the basal level of HO activity from 24, 7 ± 5.7 
mmol bilirubin/mg of protein/min to 70.0 ± 9.5 pmol bili-
humans, such as trauma, hemorrhage, thrombosis, and 
reperfusion injury. The iron release resulting from HO ac­
tivity is believed to cause increased expression of ferritin 
synthesis, which serves to sequester the metal, thus render­
ing this potential cellular oxidant inactive (42). Bilirubin 
and biliverdin both act as antioxidants in vitro and in vivo 
(24), and their increased local concentrations after HO-1 
induction may be beneficial in the protection of endothelial 
cells from injury.
Overexpression of HO-1 may not only offer a means of 
cellular protection against heme/hemoglobin-derived oxida­
tive injury, but possibly also against heme-mediated adhe­
sion molecule expression, via its degradation and elimina­
tion of heme-dependent transcriptional activation of these 
cell suiface molecules. Previous studies in our laboratory, 
using electrophoretic mobility-shift assays (EMSA) of 
nuclear protein extracts from heme-treated and control cells 
with specific oligonucleotide probes containing binding 
sites for known transcription factors, showed that heme, like 
IL-1 and TNF-cx, is a powerful and rapid activator of tran­
scription factors NF-kB, AP-2, and, to a lesser extent, AP-1 
(1). NF-kB is an early mediator of immune and inflamma­
tory responses, which, after activation, is translocated to the
rubin/mg protein/min after 24 hr of addition of heme (P < nucleus to activate responsive genes encoding defense and
0.003). On the other hand, exposure of HUVEC to TNF-a 
(20 ng/ml) for 24 hr showed a smaller increase in HO ac­
tivity (36.7 ±3.1 pmol bilirubin/mg protein/min) compared 
with the untreated cells (P < 0.035), whereas the combined 
addition of heme and TNF-a produced an enhanced re­
sponse that was higher than that observed with heme alone 
(112.3 ± 18.6 pmol bilirubin/mg protein/min; P  < 0.003).
Discussion
The experiments reported in this communication as­
sessed the expression of HO-1 and adhesion molecules 
ICAM-1, VCAM-1, and E selectin in endothelial cells in 
response to oxidative stress generated by heme. The level of 
expression of ICAM-1, VCAM-1, and E selectin proteins 
was consistently enhanced by heme in comparison to basal 
levels (Figs. 1-3). Simultaneously, HO-1 expression and 
HO activity were increased in heme-stimulated HUVEC 
(Figs. 1 and 4). TNF-a, a potent inducer of these adhesion
signaling proteins (43). Each of the examined adhesion mol­
ecules, ICAM-1, VCAM-1, and E selectin, possesses the 
regulatory sequences for the binding of NF-kB and AP-2, 
and/or AP-1 in their promoter regions, just as the acute- 
phase protein HO-1 (1, 38, 39). It is therefore possible that 
the oxidative agent heme mediates the activation of these 
genes via this pathway. Preliminary immunofluorescent re­
sults (data not shown) demonstrated that in cells pretreated 
with tin mesoporphyrin (SnMP), an inhibitor of HO activity, 
co-exposure to heme led to induction of ICAM-1. It is there­
fore likely that heme, and not one of its breakdown prod­
ucts, is responsible for the induction of adhesion molecules.
The fact that the stress protein HO-1 is simultaneously 
expressed with the adhesion molecules ICAM-1, VCAM-1, 
and E selectin after exposure to heme suggests a form of 
feedback system. It is tempting to consider this as a general 
defense against heme-mediated adhesion molecule expres­
sion, since, after inflammation, acute-phase proteins HO-1,
molecules, also induced HO-1 expression and HO activity haptoglobin, and hemopexin are rapidly expressed. Hemo-
(Figs. 1-4). pexin is a heme scavenger protein, and haptoglobin scav-
We have previously shown that transfection of the hu- enges hemoglobin. Insufficient amounts of HO-1, hemo- 
man HO-1 gene into rabbit coronary endothelial cells, using pexin, and haptoglobin may result in cells unable to defend 
adenovirus or lipofectin as a means of gene delivery, pro- themselves against large amounts of free heme, leading to 
tected endothelial cells against heme and hemoglobin tox- oxidative injury and adhesion molecule expression. This 
icity (19). Nath et ciL (42) demonstrated that in vivo indue- may explain the various complications found in sickle-cell 
tion of HO-1 prevents renal failure and drastically reduces disease, and the formation of lesions after hemorrhagic in­
mortality after glycerol-induced rhabdomyolysis in the rat, a juries (29-31, 44-46).
pathological condition that is characterized by an increased TNF-a-induced adhesion molecule expression in en-
release of myoglobin and hemoglobin into the extracellular dothelial cells has been shown to enhance the adherence of 
renal space. HO may play an important role in moderating hematopoietic cells (47, 48). We are currently investigating 
tissue damage associated with many pathologic processes in the effect of heme, heme scavengers, and heme oxygenase
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on the binding of hematopoietic cells to the vascular wall in 
relation to inflammatory disorders.
In summary, our data demonstrate that heme, in addi­
tion to catalyzing the formation of ROS (8-10), may have a 
regulatory effect on the expression of ICAM-1, VCAM-1, 
and E selectin in endothelial cells. The inducing effect of 
heme on the expression of adhesion molecules may explain 
part of the mechanism by which heme and H O I  modulate 
cellular response to inflammatory stimuli. Free heme serves, 
therefore, as a potential threat for the development of dis­
eases in which inflammatory lesions and oxidative stress 
play a role. In order to be able to correlate heme-mediated 
adhesion molecule expression to a clinical situation, we will 
further investigate the functional importance of the heme- 
mediated expression of ICAM-1, VCAM-1, and E selectin 
by studying the adherence of hematopoietic cells to the 
heme-activated vascular wall, and the possible regulatory 
role of HO-1 in this process.
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